Dermatophytic Onychomycosis Therapeutics Market Expanding due to Increasing Aging Population

Dermatophytic onychomycosis, also known as tinea unguium, refers to a fungal infection of the nail. It accounts for more than half of the cases of nail diseases. Due to this disease, nails look thickened, white, opaque, and brittle. Individuals between 60-65 years of age and particularly those with conditions such as diabetes and peripheral vascular disease have increased chances of developing dermatophytic onychomycosis. In the general population, almost 10% of the population is affected by dermatophytic onychomycosis; the condition is usually manifested by severe pain that can impede everyday functioning.

The global dermatophytic onychomycosis therapeutics (DOT) market will expand at a CAGR of 7.50% from 2015 to 2021. Due to this, the market’s valuation of more than US$3 bn in 2015 will reach US$4.7 bn by 2021.

U.S., Canada Strong Contenders in Dermatophytic Onychomycosis Therapeutics Market

In the U.S. and Canada, the prevalence of fungal infections in toenails is on the rise, which is one of the major factors driving the DOT market. Thus, North America stands as the largest regional market for dermatophytic onychomycosis therapeutics and the region held a share of more than 43% in the global market in 2014. For the 2015-2021 period, North America will exhibit the highest CAGR of 9.20% in the global market for dermatophytic onychomycosis.

Across the globe, increased awareness, coupled with increased healthcare expenditure from both healthcare agencies and individuals, is also a significant factor driving this market. Rising per capita income, increasing inclination among consumers to maintain nail aesthetics, and consistent product innovations are significantly contributing to the market’s progression.

Interested in report: Please follow the below links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/5840

However, anti-fungal drugs are associated with side effects, which is impeding the development of this market. In the under-developed regions of Asia Pacific, Latin America, and the Middle East and Africa, lack of education is another reason for the lack of awareness of the disease, which goes unnoticed many times. This is a reason restraining the development of the market as well.

View TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/5840

Nail Paint Dominates Product Segment of Global Market

The product segments of the dermatophytic onychomycosis therapeutics market are tablets and nail paints. Each segment is further sub-divided into over-the-counter and prescription products. Of the two product segments, it is the nail paint segment that will contribute a significant revenue to the global market; between 2015 and 2021 the nail paint product segment will expand at the faster CAGR of 8.30%.

On the basis of treatment, topical and oral therapy are the segments of this market. Between the two, the topical segment will be ahead and will account for almost 70% of the global market by 2021. By distribution channel, hospitals, independent pharmacies, drug stores, and mail order pharmacies are the segments of the global market for dermatophytic onychomycosis therapeutics. Of all, in 2014, drug stores contributed the highest revenue of US$1.3 bn, which represented a share of close to 47% in the global market. Independent pharmacies stood as the second largest distribution channel and accounted for almost 20% revenue of the market in 2014.

Key players that operate in the global market for dermatophytic onychomycosis therapeutics are Valeant Pharmaceuticals Inc., Novartis AG, Moberg Pharma AB, Anacor Pharmaceuticals Inc., Galderma S.A., Pfizer Inc., and Johnson & Johnson Services Inc.

About Us

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.